A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：INTEGRATIVE CANCER THERAPIES ISSN： 1534-7354 出版频率： Bi-monthly 出版社： SAGE PUBLICATIONS INC, 2455 TELLER RD, THOUSAND OAKS, USA, CA, 91320   出版社网址： http://www.sagepub.co.uk/ 期刊网址： http://www.sagepub.co.uk/journalsProdDesc.nav?prodId=Journal201510 影响因子： 3.279 主题范畴： ONCOLOGY;    INTEGRATIVE & COMPLEMENTARY MEDICINE 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and Scope: Integrative Cancer Therapies focuses on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as: treatment strategies, evaluations of current therapies, models for integrating complementary and conventional treatment in clinical practice, interventions from alternative and traditional medicine, implementing quality-of-life assessment and counseling in the clinical setting, cancer rehabilitation during and following cancer treatments, potential interactions of cancer chemotherapy drugs with frequently used dietary supplements, implementing integrative cancer care strategies into oncology practice, relevant molecular mechanisms and biology behind integrative approaches, impact of timing of chemotherapy administration on toxicity, response, and outcome by leading oncologists, researchers, and health-care professionals. Three unique features of this publication are: Integrative Grand Rounds - insightful case studies from all viewpoints of case management plus commentary from the editors. Point/Counterpoint -- lively discussions of controversial issues such as the interaction of antioxidants supplements and cancer chemotherapy or the effects of soy in treating breast cancer Patient's Perspective- authoritative analysis of new treatments being actively used by patients. This journal will be of particular interest to: medical, surgical, and radiation oncologists; clinical specialists frequently concerned with cancer such as urologists, gynecologists and women's health specialists; oncology and medical nurses; chiropractors; dietitians; pharmacists; and sophisticated lay people. Instructions to Authors Manuscript Submission Guidelines: Instructions for Submitting Papers Manuscripts should be submitted in English in triplicate. All copy must be typed double-spaced, and on one side of the sheet only (including table and figure legends and references). Do not submit diskettes with original drafts; electronic copies will be required, however, once the paper is accepted. Manuscripts should conform to the AMA Manual of Style. Be sure to retain a copy of your paper during the review process. The Authorship Responsibility, Financial Disclosure, and Copyright Transfer Forms (these appear in every issue after the Information for Authors or are available on request from the Editorial Office at ict@blockmedical.com) should accompany all manuscripts. In addition, a letter describing the submission, the category to which it belongs, and its contribution to the medical literature is required. One author should be designated the corresponding author to receive galley proofs and reprint requests. The author's complete mailing address, telephone and fax number, and email address should be included. Simultaneous submissions to other journals and previously published articles are not acceptable. Submission of a manuscript to Integrative Cancer Therapies implies commitment to publish in the journal. Each manuscript must include the following: 1. Title page, including the full article title as well as an abbreviated form of the title for a running head; the name and academic degree(s) of each author, each author's institutional affiliation, current mailing address, and business telephone and fax numbers; and the number of pages, illustrations, and tables in the manuscript.  2. An abstract of no more than 350 words. For research studies, please submit a structured abstract that summarizes the hypotheses, study design, methods, results, and conclusion. The abstract should be followed by 6 to 8 key words relating to the article.  3. Research articles should contain the following sections: Introduction (with brief literature review), Methods, Results, Discussion, and Conclusions, and may be up to 50 manuscript pages in length. Studies submitted should conscientiously adhere to ethical principles and practices, including informed consent in experiments involving human subjects, and humane practices in experiments on laboratory animals. Brief reports on preliminary research projects, of up to 10 pages, are also welcomed. 4. Review papers should include scholarly considerations and clinical implications, and may be up to 100 manuscript pages in length. 5. Case reports should explain the significance of the case, including relevant patient information, results of diagnostic tests, description of treatment and outcome, and may be up to 10 manuscript pages in length. 6. Educational articles provide shorter summaries of the state of research or practice in a facet of integrative cancer treatment. They may be up to 50 manuscript pages in length, should include a reference list, and should chiefly address the interests of practitioners. 7. Letters to the Editor of up to 1000 words in length will be considered. Those wishing to submit an Integrative Tumor Board or Point-Counterpoint should contact the editors. Permissions. Submit with the manuscript written permissions to use nonoriginal materials (quotations of over 100 words in length, or any table or figure), from both the author and publisher of the original. Credit the source in the text or as a footnote in a figure legend. Any photographs of identifiable persons should be accompanied by signed releases that show informed consent. References should be cited in the text using superscripted numbers, in numerical order; once a reference is cited, all subsequent citations of the same reference should use the original number (do not use ibid. or op. cit.). The journal uses the AMA reference style. Figures submitted with manuscripts should be glossy prints or good-quality laser-printed illustrations. Photocopies are not acceptable. Copies of tables and illustrations, with labels and legends, should be of suitable quality to enable the referees to evaluate them. Electronic copies of figures must be submitted to the publisher; thus, we encourage the submission of figures electronically in the following formats: .tiff, .eps, .jpeg, and .prig. These may be submitted on diskette with the revised manuscript following acceptance. The figures should be numbered in the order in which they are discussed in the text. All figures should be mentioned in the text. The first author's last name, the figure number, and an arrow to indicate the top edge of the figure should be on a label pasted on the back of each figure. Tables should be numbered in the order in which they are mentioned in the text. Color figures or tables will be subject to a publication charge: please contact the editors about this. Tables should be used to present data and should have concise titles. Place each table on a separate page. Abbreviations should be introduced after the first occurrence of the term being abbreviated. Use standard metric units for measurements. Please list sources of support such as grants. These may be included in an acknowledgments section placed after the discussion and conclusions. For manuscripts not accepted for publication, one copy of the manuscript and glossy photographs will be returned to the corresponding author along with the reviewers' comments. Reprints. Authors will receive a schedule of reprint costs with galley proofs. Requests for reprints should be sent to Reprint Department, Sage Science Press, 2455 Teller Road, Thousand Oaks, CA 91320; or e-mail: reprint@sagepub.com Submit manuscripts to: Keith I. Block, M.D., Editor-in-Chief, Integrative Cancer Therapies Institute for Integrative Cancer Care 1800 Sherman Avenue, Suite 515 Evanston IL, 60201 USA Telephone: 847-492-3040 E-mail: ict@blockmedical.com For inquiries about the status of manuscripts after submission, please contact: Charlotte Gyllenhaal, Ph.D. Associate Editor, Integrative Cancer Therapies Institute for Integrative Cancer Care 1800 Sherman Avenue, Suite 515 Evanston IL, 60201 USA Telephone: 847-492-3040 E-mail: cgyllenhaal@blockmedical.com To subscribe to Integrative Cancer Therapies, please visit http://www.sagepub.com or www.sagesciencepress.com and search under "Integrative Cancer Therapies." Authors who want to refine the use of English in their manuscripts might consider utilizing the services of SPi, a non-affiliated company that offers Professional Editing Services to authors of journal articles in the areas of science, technology, medicine or the social sciences. SPi specializes in editing and correcting English-language manuscripts written by authors with a primary language other than English. Visit http://www.prof-editing.com for more information about SPi's Professional Editing Services, pricing, and turn-around times, or to obtain a free quote or submit a manuscript for language polishing. Please be aware that SAGE has no affiliation with SPi and makes no endorsement of the company. An author's use of SP's services in no way guarantees that his or her submission will ultimately be accepted. Any arrangement an author enters into will be exclusively between the author and SPi, and any costs incurred are the sole responsibility of the author. Editorial Board Editorial Board: Associate Editor Charlotte Gyllenhaal, PhD Institute for Integrative Cancer Care   International Editor Jacob Shoham, MD, PhD Bar-Ilan University, Ramat-Gan, Israel   Assistant Editors Penny B. Block, MA Institute for Integrative Cancer Care Henry Dreher, MA Mark Mead, MS Daniel Rubin, ND   Corresponding Editor Ralph W. Moss, PhD Cancer Decisions   Advisory Board Members Norman R. Farnsworth, PhD University of Illinois at Chicago James S. Gordon, MD Center for Mind-Body Medicine William J.M. Hrushesky, MD Dorn Veterans Affairs Medical Center Wayne Jonas, MD Uniformed Services University of the Health Sciences Robert Oldham, MD Cancer Therapeutics, Inc John Pezzuto, PhD Purdue University Azra Raza, MD Rush Presbyterian Hospital Dennis Roth Morristown, NJ Julia Rowland, PhD National Cancer Institute Leslie Sandlow, MD University of Illinois at Chicago Stephen P. Tomasovic, PhD MD Anderson Cancer Center Debu Tripathy, MD University of Texas, Southwestern Medical Center Nicholas Vogelzang, MD Nevada Cancer Institute   Editorial Board Anton Bilchik, MD Santa Monica, CA Dave Blask, PhD, MD Bassett Research Institute Peter Boasberg, MD John Wayne Cancer Institute Phyllis Bowen, PhD University of Illinois at Chicago D. Barry Boyd, MD Integrative Oncology Terence Bugno, MD Northern Illinois Center for Cancer Care Raymond Chang, MD Institute of East-West Medicine Lorenzo Cohen, PhD M.D. Anderson Cancer Center Geoffrey Cordell, PhD University of Illinois at Chicago Miriam Piven Cotler, PhD California State University, Northridge, California Michael de la Torre, MD Institute for Integrative Cancer Care Lorne Feldman, MD California Hematology Oncology Medical Group Richard Fleming, MD The Fleming Heart & Health Institute Jeremy Geffen, MD Geffen Visions International Steven Greer, MD St. Raphael's Hospice David M. Gustin, MD Illinois Masonic Medical Center Michael J. Hawkins, MD Washington Cancer Institute Arika Hirsch, MD Associated Radiologists, Ltd Judith Jacobsen, MD Columbia University College of Physicians and Surgeons John Knaus, DO St. Francis Hospital Lawrence Kushi, ScD Columbia University Teachers College Robert A. Nagourney, MD Rational Therapeutics Inc Alfred I. Neugut, MD, PhD Columbia University Presbyterian Hospital Faith Ottery, MD, PhD, FACN The Society for Nutritional Oncology Adjuvant Therapy Louis L. Pisters, MD M.D. Anderson Cancer Center Mark Renneker, MD School of Medicine, University of California, San Francisco Stephen M. Sagar, MD Hamilton Regional Cancer Centre Carole M. Schneider, PhD University of Northern Colorado Victor S. Sierpina University of Texas Leo Stolbach, MD St. Vincent Hospital Lydia Temoshok, PhD Maryland Biotechnology Center Jeanne Wallace Nutritional Solutions   Editorial Consultants Timothy C. Birdsall, ND Midwestern Regional Medical Center Mark Blumenthal American Botanical Council Michael Broffman, LAc Pine Street Clinic Nischala Devi Abundant Well-Being Gar Hildenbrand Gerson Research Organization Barry Krost, MA Creative Healing Institute Mark Myers, RD Institute for Integrative Cancer Care R Deva Nathan, MD OLR Cancer Center Donald R. Yance Jr., CN, MH, AHG Centre for Natural Healing